# AMPHOTERICIN B
> **ANDA212967** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2025-06-30
## Drug
- **FDA Application Number:** ANDA212967
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMPHOTERICIN B
- **Generic name:** AMPHOTERICIN B LIPOSOME
- **Active ingredients:** AMPHOTERICIN B
- **Dosage form:** INJECTABLE, LIPOSOMAL
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MYLAN LABS LTD
- **Manufacturer:** Mylan Institutional LLC
- **First approval:** 2025-06-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212967)
---
*MORVS · CC0 1.0*